GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 29, 2026, 4:00 PM EST

GlobeStar Therapeutics Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Revenue
----00
Revenue Growth
-----81.88%-52.25%
Gross Profit
----0-0.040
Operating Income
-0.8-1.86-1.27-9.09-0.3-0.32
Net Income
-0.92-1.95-1.49-9.8-0.54-2.28
Earnings Per Share
-0.00-0.00-0.00-0.02-0.00-0.02
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Cash & Investments
000.010.010.080.1
Total Debt
0.330.370.160.110.160.11
Net Cash (Debt)
-0.33-0.37-0.15-0.1-0.07-0.01
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-0.00

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Operating Cash Flow
-0.15-0.21-0.33-0.75-0.24-0.26
Capital Expenditures
-----0-
Free Cash Flow
-0.15-0.21-0.33-0.75-0.24-0.26
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Gross Margin
-----63.77%
Operating Margin
-----394377.92%-74322.35%
Pretax Margin
-----703546.75%-158840.47%
Profit Margin
-----703546.75%-535311.06%
FCF Margin
-----313658.44%-61208.94%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
PS Ratio
----38523.182366.49